OIA
TEVA icon

Optimum Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Optimum Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-500
Closed -$1K – 1032
2018
Q3 		$1K Hold
500
– – ﹤0.01% 1017
2018
Q2 		$2K Buy
+500
New +$10.2K ﹤0.01% 1006

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Optimum Investment Advisors's TEVA Position: Q3 2025 in Review

Optimum Investment Advisors increased its Teva Pharmaceuticals (TEVA) stake by 7,281% in Q3 2025, buying an estimated $307K and bringing the position to 17,715 shares worth $358K. The position accounts for 0.14% of the portfolio, ranked #130.

Optimum Investment Advisors first reported a position in TEVA in Q3 2013 and has held it in 46 quarters since. The position peaked at $1.13M in Q4 2015. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Optimum Investment Advisors held 17,715 shares of Teva Pharmaceuticals worth $358K as of Q3 2025.
  • Optimum Investment Advisors bought 17,475 Teva Pharmaceuticals shares in Q3 2025, an estimated $307K.
  • Teva Pharmaceuticals made up 0.14% of Optimum Investment Advisors's portfolio in Q3 2025, its #130 holding.
  • Optimum Investment Advisors first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 46 quarters since.
  • Optimum Investment Advisors's Teva Pharmaceuticals position peaked at $1.13M in Q4 2015.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.